Samir Saheb

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.

Journal: Atherosclerosis
Published: December 18, 2025

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.

Journal: Blood advances
Published: July 01, 2025

Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary.

Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary.

Journal: Future cardiology
Published: June 23, 2025

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Journal: Revue neurologique
Published: April 22, 2025

Comparison of the Efficacy of Polyvalent Intravenous Immunoglobulins and Therapeutic Plasma Exchange in Anti-NMDAR Encephalitis in the ICU.

Comparison of the Efficacy of Polyvalent Intravenous Immunoglobulins and Therapeutic Plasma Exchange in Anti-NMDAR Encephalitis in the ICU.

Journal: Neurocritical care
Published: April 09, 2025

Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19.

Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19.

Journal: Frontiers in immunology
Published: September 07, 2024

Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.

Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 02, 2024

Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy.

Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy.

Journal: European heart journal
Published: October 20, 2023

Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.

Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.

Journal: American journal of ophthalmology
Published: January 01, 2023

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

Journal: Cancer discovery
Published: October 18, 2022

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey.

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey.

Journal: Orphanet journal of rare diseases
Published: February 21, 2021

Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study.

Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study.

Journal: Frontiers in immunology
Published: February 19, 2021
Showing 1-12 of 40

Last Updated: 09/26/2026